UB317
TargetsGLP-1; GIP
IndicationsNonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Obstructive sleep apnoea syndrome; Cardiac failure with preserved ejection fraction
ClinicalIND
TherapeuticsMetabolic & Endocrinology
ModalitiesPeptide
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →